The global biodefense market size is expected to exhibit moderate growth during 2021-2026.
Sheridan, United States - August 11, 2021 /MarketersMedia/ —
According to the latest report by IMARC Group, titled “Biodefense Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global biodefense market size is expected to exhibit moderate growth during 2021-2026. Looking forward, IMARC Group expects the global biodefense market to grow at a CAGR of around 6% during 2021-2026. Biodefense includes the utilization of several medical and military measures that are taken to safeguard individuals against bioterrorism. Bioterrorism refers to the usage of biological toxins or infectious agents that can be used with the intent to kill or infect humans and instigate biological warfare. It involves using several living organisms, such as bacteria, viruses, fungi, and toxins, that can result in causing chronic illnesses among animals and humans while acting as a threat to the environment as well. Numerous interventions, including drugs and vaccinations, can help counter the acts of bioterrorism by limiting the spread of the disease. Apart from this, conducting research and specific public health procedures can also aid in protecting individuals against biological threats and providing necessary medical care to the affected.
Request Free Sample Report: https://www.imarcgroup.com/biodefense-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Market Trends:
The global market is primarily driven by the growing awareness regarding bioterrorism, along with the increasing tensions between several nations. This has encouraged the governments of these countries to expand their defense budgets and invest in biodefense in an attempt to equip the public healthcare system with an efficient disease surveillance system that takes rapid actions to counter biological threats. Additionally, they are undertaking initiatives to increase the funding for procuring, developing and utilizing advanced medical countermeasures against biological, chemical, radiological, and nuclear (CBRN) warfare agents. Moreover, continual technological advancements in the field of genetic engineering and biotechnology are creating a positive outlook for the market. Numerous players are also leveraging these advanced technologies to launch innovative biothreat detection devices that assist in the identification of several viruses and bacteria in an efficient manner. The market is further driven by the escalating need for effective medical measures and threat detection procedures on account of the rapid outbreak of the COVID-19 pandemic.
Ask Customization and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/biodefense-market
Key Market Segmentation:
Competitive Landscape with Key Player:
Achaogen Inc.
Alnylam Pharmaceuticals Inc.
Altimune Inc. (PharmAthene Inc.)
Bavarian Nordic A/S
Cleveland BioLabs Inc.
Dynavax Technologies Corporation
Dynport Vaccine Company LLC (General Dynamics Corporation)
Elusys Therapeutics Inc.
Emergent Biosolutions Inc.,
Ichor Medical Systems Inc.
Ology Bioservices Inc.
SIGA Technologies, Inc.
Market Breakup by End-User:
Hospitals and Clinics
Ambulatory Care Centers
Others
Market Breakup by Biothreat Detection Device:
Samplers
Detectors/Triggering Devices
Identifiers
Assays
Others
Market Breakup by Vaccine Type:
Anthrax
Smallpox
Botulism
Others
Market Breakup by Region:
North America
Europe Asia Pacific
Latin America
Middle East and Africa
Key Highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Report:
Metal Powder Market: https://www.imarcgroup.com/metal-powder-market
Potato Protein Market: https://www.imarcgroup.com/potato-protein-market
Cybersecurity Market: https://www.imarcgroup.com/cybersecurity-market
Bronchodilator Market: https://www.imarcgroup.com/bronchodilators-market
Virtual Reality Market: https://www.imarcgroup.com/virtual-reality-market
France Silica Sand Market: https://www.imarcgroup.com/france-silica-sand-market
GCC Paper Products Market: https://www.imarcgroup.com/gcc-paper-products-market
Qatar Greenhouse Market: https://www.imarcgroup.com/qatar-greenhouse-market
Power Plant Boiler Market: https://www.imarcgroup.com/power-plant-boiler-market
E-Cigarette Market: https://www.imarcgroup.com/e-cigarette-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Contact Info:
Name: Elena Anderson
Email: Send Email
Organization: IMARC Group
Address: 30 N Gould St, Ste R
Phone: 6317911145
Website: https://www.imarcgroup.com/
Source: MarketersMedia
Release ID: 89041035
